Welcome to the World of Kapruvia®: The Game-Changer in CKD-Associated Pruritus Treatment What is Kapruvia®? Kapruvia® (difelikefalin) has recently made waves in the medical world as the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients. This groundbreaking therapy has been approved in Switzerland…
Class Action Lawsuit Filed Against Wells Fargo & Company Investors Beware In a recent development, the renowned law firm Bronstein, Gewirtz & Grossman, LLC has taken legal action against Wells Fargo & Company, a prominent player in the financial industry. The lawsuit, filed on behalf of investors who have purchased or acquired shares of Wells…
Finance Magnates London Summit 2022: A Decade of Networking and Innovation Are You Ready for the Largest B2B Event of the Fall? Finance Magnates London Summit (FMLS) is coming soon, billed as one of the largest B2B events this fall. FMLS will be celebrating its decade-long run with the largest installment to date, taking place…
Important Update: Lantronix Fourth Quarter and Fiscal 2022 Results Rescheduled to August 25, 2022. IRVINE, Calif., Aug. 18, 2022 (GLOBE NEWSWIRE) — Lantronix, Inc. (the “Company”) (NASDAQ: LTRX), a global provider of secure turnkey solutions for the Internet of Things (IoT) and Remote Environment Management (REM) offering Software as a Service (SaaS), connectivity services, engineering…
KULR Secures Second Order from Fortune 20 E-Commerce and Cloud Computing Customer for Commercial Drones San Diego, Aug. 18, 2022 (GLOBE NEWSWIRE) KULR Technology Group, Inc. (NYSE American: KULR) (the “Company” or “KULR”), a leading developer of next-generation lithium-ion (“Li-ion”) battery safety and thermal management technologies, has received two orders from a leading Fortune 20…
Corporate Bond Auctions: A New Opportunity for Investors Exciting news for investors! Are you ready for the week starting 19 September? Corporate bond auctions are set to commence from the week starting 19 September, offering a new opportunity for investors to diversify their portfolios and potentially increase their returns. This initiative opens up a new…
Revolutionizing Oncology Clinical Trials Accelerating Patient Enrollment for the Benefit of Oncology Patients Science 37 and Syapse: A Game-Changing Partnership Oncology clinical trials have long been plagued by slow patient enrollment, leading to delays in the development of innovative treatments and therapies. However, a recent partnership between Science 37 and Syapse is set to revolutionize…
Breaking Records: Marex Sees 29% Increase in Net Revenues During H1 2022! Record-Breaking Growth for Marex in H1 2022 On 18 August, Marex reported its financial results for the six months ended 30 June 2022. With net revenues of $334.1 million, Marex saw solid growth of 29% YoY in the mentioned period. During the first…
